Cambridge, UK - 17th October 2017
The news of the completion of Nuformix’s acquisition by Levrett plc was covered in The Times by Richard Fletcher.
The article summarises how shares in the investment company formerly known as Levrett rose by more than 7% to 3.75p after the reverse takeover of Nuformix (NFX), the British pharmaceuticals development company, for £12 million. Trading in the cash shell, which listed in December 2015, had been suspended at 3.5p, but the shares were relisted after approval of the deal at an annual meeting. After the relisting, the company changed its name to Nuformix.
Link to the full article here (subscription required)